Verified Nov 2026
Other
·

Hyderabad, Telangana
·
Since 1984
Dr. Reddy's Laboratories is an Indian multinational pharmaceutical manufacturer headquartered in Hyderabad, founded in 1984. The company employs 10,000–50,000 people and generates $1–5 billion in annual revenue. It produces generic formulations, active pharmaceutical ingredients, and specialty medicines across oncology, cardiology, and other therapeutic areas, serving over half a billion patients in 66 countries. In September 2025, the company acquired Stugeron, an anti-vertigo brand, from Johnson & Johnson.
Dr. Reddy's Laboratories at a glance
Revenue
$1-5B
Est. band
Employees
10,000-50,000
Founded
1984
Headquarters
Hyderabad, Telangana
Import activity
5332
Industries
Automotive
Electric Vehicles
Medical
Industrial Equipment
Sourcing and import activity
From US customs bill-of-lading records
US sea imports
5332
Named foreign suppliers
50
Top origins
India · Oman · Sri Lanka · Italy

Shared foreign counterparties do not establish that these companies buy from Dr. Reddy's Laboratories.
What this tells a buyer
Dr. Reddy's received approximately 5,332 pharmaceutical shipments, with originating points spanning India, China, Italy, Oman, Sri Lanka, and 14 other countries across four continents.
The company manufactures over 190 medications, 60 active pharmaceutical ingredients including highly potent APIs, and develops oncology biosimilar therapies.
Dr. Reddy's is a publicly traded multinational with a market capitalization exceeding $13.5 billion and significant market presence across North America, Europe, India, and emerging markets.
Source: US customs bill-of-lading records and public filings · Last verified Nov 13, 2026
STABILITY SIGNALS
Established & active
42 years in operation (founded 1984).
5,332 US import shipments on record.
Overview
Dr. Reddy's Laboratories is an Indian multinational pharmaceutical manufacturer headquartered in Hyderabad, founded in 1984. The company employs 10,000–50,000 people and generates $1–5 billion in annual revenue. It produces generic formulations, active pharmaceutical ingredients, and specialty medicines across oncology, cardiology, and other therapeutic areas, serving over half a billion patients in 66 countries. In September 2025, the company acquired Stugeron, an anti-vertigo brand, from Johnson & Johnson.
At a glance
Attribute | Detail |
|---|---|
Founded | 1984 |
Headquarters | Hyderabad, Telangana |
Employees | 10,000-50,000 |
Revenue | $1-5B (estimated) |
What Dr. Reddy's Laboratories makes
The company manufactures over 190 medications, 60 active pharmaceutical ingredients including highly potent APIs, and develops oncology biosimilar therapies.
Trade and customs footprint
Dr. Reddy's received approximately 5,332 pharmaceutical shipments, with originating points spanning India, China, Italy, Oman, Sri Lanka, and 14 other countries across four continents. US customs bill-of-lading records list 5332 inbound shipments across 50 foreign suppliers, with top origins including India · Oman · Sri Lanka · Italy.
Latest developments
2025-09-11 — Dr Reddy's Laboratories Acquires J&J's Anti-Vertigo Brand Stugeron for $50.5 Million, ETPharma (indiatimes.com)
2025-04-07 — Kyndryl partners with Dr. Reddy’s Laboratories (kyndryl.com)
Company details
Dr. Reddy's is a publicly traded multinational with a market capitalization exceeding $13.5 billion and significant market presence across North America, Europe, India, and emerging markets. Dr. Reddy's Laboratories was founded in 1984, has an estimated 10,000-50,000 employees, and is headquartered in Hyderabad, Telangana. On the LightSource stability read it is rated "Established & active": 42 years in operation (founded 1984). 5,332 US import shipments on record.
Frequently asked questions
What does Dr. Reddy's Laboratories do?
Dr. Reddy's Laboratories is an Indian multinational pharmaceutical manufacturer headquartered in Hyderabad, founded in 1984. The company employs 10,000–50,000 people and generates $1–5 billion in annual revenue. It produces generic formulations, active pharmaceutical ingredients, and specialty medicines across oncology, cardiology, and other therapeutic areas, serving over half a billion patients in 66 countries. In September 2025, the company acquired Stugeron, an anti-vertigo brand, from Johnson & Johnson.
Where is Dr. Reddy's Laboratories headquartered?
Dr. Reddy's Laboratories is headquartered in Hyderabad, Telangana.
When was Dr. Reddy's Laboratories founded?
Dr. Reddy's Laboratories was founded in 1984.
How big is Dr. Reddy's Laboratories?
Dr. Reddy's Laboratories has an estimated 10,000-50,000 employees, with revenue in the $1-5B range (estimated).
Does Dr. Reddy's Laboratories import from overseas suppliers?
US customs bill-of-lading records show 5332 inbound shipments for Dr. Reddy's Laboratories, with top origins including India · Oman · Sri Lanka · Italy.
Related suppliers
Explore other suppliers in the LightSource directory:
Last verified Nov 2026. Is this your company? Request a correction.
Location & contact
Evaluating suppliers like these?
This profile is part of a public-data sample of the full LightSource directory. Book a demo to see the full LightSource marketplace and supplier discovery platform — 1M+ credible suppliers, with AI-run sourcing events.
